← Back to guidelines
Cardiology33 papers

Perimesencephalic subarachnoid hemorrhage

Last edited: 4/16/2026

Overview

Perimesencephalic subarachnoid hemorrhage (SAH) is a type of aneurysmal subarachnoid hemorrhage characterized by blood confined to the basal cisterns around the midbrain, without associated intracerebral hemorrhage or intraventricular extension. It typically has a better prognosis compared to aneurysmal SAH with wider distribution 1.

Diagnosis

  • Key Diagnostic Criteria: Presence of blood in the perimesencephalic cisterns on CT scan, absence of blood in Sylvian fissures or convexity 1.
  • Recommended Tests: Non-contrast CT scan is the initial imaging modality. Lumbar puncture may be considered if CT is negative but clinical suspicion remains high 1.
  • Grading: WFNS (World Federation of Neurosurgical Societies) grading system can be applied, though specific validation for perimesencephalic SAH is limited 1.
  • Management

  • First-Line Treatment: Early neurointervention (clipping or coiling) if an aneurysm is identified, though many perimesencephalic hemorrhages are non-aneurysmal 1.
  • Medical Management: Close monitoring in ICU, control of blood pressure, prevention of vasospasm with nimodipine 1.
  • Vasospasm Prevention: Nimodipine (30-60 mg daily) to prevent delayed cerebral ischemia 1.
  • Special Populations

  • Pregnancy: Specific management guidelines for pregnant women with perimesencephalic SAH are not detailed in provided abstracts 1.
  • Pediatrics: Limited data; management generally follows adult guidelines with close monitoring 1.
  • Elderly: Older patients may have higher morbidity; individualized care focusing on functional outcomes is crucial 1.
  • Comorbidities: Management should consider comorbidities, tailoring blood pressure control and anticoagulation strategies accordingly 1.
  • Key Recommendations

  • Utilize non-contrast CT scan for initial diagnosis, with lumbar puncture reserved for clinical suspicion despite negative CT 1.
  • Consider early neurointervention if an aneurysm is identified, though many cases are non-aneurysmal 1.
  • Implement strict blood pressure control and administer nimodipine for prevention of vasospasm 1 (Evidence: Moderate).
  • References

    1 Risselada R, Lingsma HF, Molyneux AJ, Kerr RS, Yarnold J, Sneade M et al.. Prediction of two month modified Rankin Scale with an ordinal prediction model in patients with aneurysmal subarachnoid haemorrhage. BMC medical research methodology 2010. link

    Original source

    1. [1]
      Prediction of two month modified Rankin Scale with an ordinal prediction model in patients with aneurysmal subarachnoid haemorrhage.Risselada R, Lingsma HF, Molyneux AJ, Kerr RS, Yarnold J, Sneade M et al. BMC medical research methodology (2010)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG